Ballentine Partners’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.39M | Sell |
34,261
-434
| -1% | -$30.3K | 0.04% | 170 |
|
|
2025
Q1 | $2.55M | Buy |
34,695
+4,173
| +14% | +$307K | 0.04% | 154 |
|
|
2024
Q4 | $2M | Sell |
30,522
-1,769
| -5% | -$116K | 0.03% | 174 |
|
|
2024
Q3 | $2.52M | Buy |
32,291
+3,564
| +12% | +$278K | 0.04% | 145 |
|
|
2024
Q2 | $2.24M | Buy |
28,727
+5,112
| +22% | +$399K | 0.04% | 146 |
|
|
2024
Q1 | $1.6M | Buy |
23,615
+5,795
| +33% | +$393K | 0.03% | 180 |
|
|
2023
Q4 | $1.2M | Buy |
17,820
+2,325
| +15% | +$157K | 0.02% | 205 |
|
|
2023
Q3 | $1.05M | Sell |
15,495
-300
| -2% | -$20.3K | 0.02% | 195 |
|
|
2023
Q2 | $1.13M | Buy |
15,795
+3,769
| +31% | +$270K | 0.03% | 184 |
|
|
2023
Q1 | $835K | Sell |
12,026
-40
| -0.3% | -$2.78K | 0.02% | 220 |
|
|
2022
Q4 | $818K | Buy |
12,066
+3,194
| +36% | +$217K | 0.02% | 196 |
|
|
2022
Q3 | $487K | Sell |
8,872
-465
| -5% | -$25.5K | 0.02% | 249 |
|
|
2022
Q2 | $618K | Buy |
9,337
+1,807
| +24% | +$120K | 0.02% | 209 |
|
|
2022
Q1 | $499K | Buy |
7,530
+23
| +0.3% | +$1.52K | 0.02% | 256 |
|
|
2021
Q4 | $437K | Sell |
7,507
-311
| -4% | -$18.1K | 0.01% | 297 |
|
|
2021
Q3 | $470K | Buy |
7,818
+645
| +9% | +$38.8K | 0.02% | 248 |
|
|
2021
Q2 | $430K | Buy |
7,173
+6
| +0.1% | +$360 | 0.01% | 261 |
|
|
2021
Q1 | $356K | Buy |
7,167
+323
| +5% | +$16K | 0.01% | 274 |
|
|
2020
Q4 | $342K | Sell |
6,844
-490
| -7% | -$24.5K | 0.01% | 259 |
|
|
2020
Q3 | $402K | Buy |
7,334
+531
| +8% | +$29.1K | 0.02% | 231 |
|
|
2020
Q2 | $360K | Buy |
6,803
+234
| +4% | +$12.4K | 0.02% | 237 |
|
|
2020
Q1 | $293K | Buy |
6,569
+63
| +1% | +$2.81K | 0.02% | 248 |
|
|
2019
Q4 | $324K | Buy |
6,506
+817
| +14% | +$40.7K | 0.01% | 289 |
|
|
2019
Q3 | $254K | Buy |
5,689
+166
| +3% | +$7.41K | 0.01% | 318 |
|
|
2019
Q2 | $228K | Buy |
+5,523
| New | +$228K | 0.01% | 339 |
|